000 | 01629 a2200421 4500 | ||
---|---|---|---|
005 | 20250515064128.0 | ||
264 | 0 | _c20070817 | |
008 | 200708s 0 0 eng d | ||
022 | _a0066-4804 | ||
024 | 7 |
_a10.1128/AAC.00831-06 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDurand-Gasselin, Lucie | |
245 | 0 | 0 |
_aEvidence and possible consequences of the phosphorylation of nucleoside reverse transcriptase inhibitors in human red blood cells. _h[electronic resource] |
260 |
_bAntimicrobial agents and chemotherapy _cJun 2007 |
||
300 |
_a2105-11 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAdenine _xadministration & dosage |
650 | 0 | 4 |
_aAnti-HIV Agents _xadministration & dosage |
650 | 0 | 4 | _aDrug Interactions |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 |
_aErythrocytes _xmetabolism |
650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLamivudine _xadministration & dosage |
650 | 0 | 4 |
_aNucleosides _xadministration & dosage |
650 | 0 | 4 |
_aOrganophosphonates _xadministration & dosage |
650 | 0 | 4 | _aPhosphorylation |
650 | 0 | 4 |
_aReverse Transcriptase Inhibitors _xadministration & dosage |
650 | 0 | 4 | _aTenofovir |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aZidovudine _xadministration & dosage |
700 | 1 | _aDa Silva, David | |
700 | 1 | _aBenech, Henri | |
700 | 1 | _aPruvost, Alain | |
700 | 1 | _aGrassi, Jacques | |
773 | 0 |
_tAntimicrobial agents and chemotherapy _gvol. 51 _gno. 6 _gp. 2105-11 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1128/AAC.00831-06 _zAvailable from publisher's website |
999 |
_c16988385 _d16988385 |